Arjun Krishnan

Arjun Krishnan is Apollo Therapeutics’ chief business officer. Prior to joining Apollo, Arjun worked with a range of growth equity and venture backed businesses in various segments of healthcare, including biotech, medtech and healthtech. Previously, he led business development at BTG Plc, subsequently taking on operating leadership roles within BTG’s global pulmonology business unit, which developed and commercialized therapies for the treatment of COPD. Arjun started his career on Wall Street within equity research at JPMorgan, following which he was an investor in public and private companies in the healthcare sector at Magnetar Capital and HealthCor. He received a bachelor’s degree in quantitative analysis from Franklin & Marshall College.